Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.

Anna Ruiz-Llobet Susanna GassiotEdurne SarrateJosune ZubicarayJosé Luis DapenaSusana RivesJulián SevillaÁngela Menárguez LópezMelissa Panesso RomeroCatalina MontoyaJosé Manuel VagaceJosé Ramón Molina HurtadoMarina García-MorínMiriam García AbósMaría Carmen Mendoza SánchezFrancisco LendínezPilar Palomo MoraledaMaría TallónBerta GonzálezEmilia UrrutiaJosé Vicente SernaIrene Peláez PleguezuelosMarta Martínez MerinoEduardo Ramos ElbalElena OrellanaHelga Benítez MuñozRubén Berrueco

Published in: Journal of thrombosis and haemostasis : JTH (2022)

Most of the VTE cases occurred in patients without inherited thrombophilia, but when it is present, the VTE risk is higher. LMWH administration was useful to decrease VTE in these patients.

Keyphrases

venous thromboembolism
end stage renal disease
acute lymphoblastic leukemia
risk factors
ejection fraction
direct oral anticoagulants
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
atrial fibrillation
rectal cancer